Miscellaneous Antimalarials Market, Global Outlook and Forecast 2024-2031

Report ID: 1133781 | Published Date: Jan 2025 | No. of Page: 64 | Base Year: 2024 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Miscellaneous Antimalarials Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Miscellaneous Antimalarials Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Miscellaneous Antimalarials Overall Market Size
    2.1 Global Miscellaneous Antimalarials Market Size: 2021 VS 2028
    2.2 Global Miscellaneous Antimalarials Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Miscellaneous Antimalarials Players in Global Market
    3.2 Top Global Miscellaneous Antimalarials Companies Ranked by Revenue
    3.3 Global Miscellaneous Antimalarials Revenue by Companies
    3.4 Top 3 and Top 5 Miscellaneous Antimalarials Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Miscellaneous Antimalarials Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Miscellaneous Antimalarials Players in Global Market
        3.6.1 List of Global Tier 1 Miscellaneous Antimalarials Companies
        3.6.2 List of Global Tier 2 and Tier 3 Miscellaneous Antimalarials Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Miscellaneous Antimalarials Market Size Markets, 2021 & 2028
        4.1.2 Doxycyline
        4.1.3 Pyrimethamine
        4.1.4 Halofantrine
    4.2 By Type - Global Miscellaneous Antimalarials Revenue & Forecasts
        4.2.1 By Type - Global Miscellaneous Antimalarials Revenue, 2017-2022
        4.2.2 By Type - Global Miscellaneous Antimalarials Revenue, 2023-2028
        4.2.3 By Type - Global Miscellaneous Antimalarials Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Miscellaneous Antimalarials Market Size, 2021 & 2028
        5.1.2 Prevention
        5.1.3 Treatment
    5.2 By Application - Global Miscellaneous Antimalarials Revenue & Forecasts
        5.2.1 By Application - Global Miscellaneous Antimalarials Revenue, 2017-2022
        5.2.2 By Application - Global Miscellaneous Antimalarials Revenue, 2023-2028
        5.2.3 By Application - Global Miscellaneous Antimalarials Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Miscellaneous Antimalarials Market Size, 2021 & 2028
    6.2 By Region - Global Miscellaneous Antimalarials Revenue & Forecasts
        6.2.1 By Region - Global Miscellaneous Antimalarials Revenue, 2017-2022
        6.2.2 By Region - Global Miscellaneous Antimalarials Revenue, 2023-2028
        6.2.3 By Region - Global Miscellaneous Antimalarials Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Miscellaneous Antimalarials Revenue, 2017-2028
        6.3.2 US Miscellaneous Antimalarials Market Size, 2017-2028
        6.3.3 Canada Miscellaneous Antimalarials Market Size, 2017-2028
        6.3.4 Mexico Miscellaneous Antimalarials Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Miscellaneous Antimalarials Revenue, 2017-2028
        6.4.2 Germany Miscellaneous Antimalarials Market Size, 2017-2028
        6.4.3 France Miscellaneous Antimalarials Market Size, 2017-2028
        6.4.4 U.K. Miscellaneous Antimalarials Market Size, 2017-2028
        6.4.5 Italy Miscellaneous Antimalarials Market Size, 2017-2028
        6.4.6 Russia Miscellaneous Antimalarials Market Size, 2017-2028
        6.4.7 Nordic Countries Miscellaneous Antimalarials Market Size, 2017-2028
        6.4.8 Benelux Miscellaneous Antimalarials Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Miscellaneous Antimalarials Revenue, 2017-2028
        6.5.2 China Miscellaneous Antimalarials Market Size, 2017-2028
        6.5.3 Japan Miscellaneous Antimalarials Market Size, 2017-2028
        6.5.4 South Korea Miscellaneous Antimalarials Market Size, 2017-2028
        6.5.5 Southeast Asia Miscellaneous Antimalarials Market Size, 2017-2028
        6.5.6 India Miscellaneous Antimalarials Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Miscellaneous Antimalarials Revenue, 2017-2028
        6.6.2 Brazil Miscellaneous Antimalarials Market Size, 2017-2028
        6.6.3 Argentina Miscellaneous Antimalarials Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Miscellaneous Antimalarials Revenue, 2017-2028
        6.7.2 Turkey Miscellaneous Antimalarials Market Size, 2017-2028
        6.7.3 Israel Miscellaneous Antimalarials Market Size, 2017-2028
        6.7.4 Saudi Arabia Miscellaneous Antimalarials Market Size, 2017-2028
        6.7.5 UAE Miscellaneous Antimalarials Market Size, 2017-2028
7 Players Profiles
    7.1 Norvatis
        7.1.1 Norvatis Corporate Summary
        7.1.2 Norvatis Business Overview
        7.1.3 Norvatis Miscellaneous Antimalarials Major Product Offerings
        7.1.4 Norvatis Miscellaneous Antimalarials Revenue in Global Market (2017-2022)
        7.1.5 Norvatis Key News
    7.2 Teva Pharmaceutical Industries
        7.2.1 Teva Pharmaceutical Industries Corporate Summary
        7.2.2 Teva Pharmaceutical Industries Business Overview
        7.2.3 Teva Pharmaceutical Industries Miscellaneous Antimalarials Major Product Offerings
        7.2.4 Teva Pharmaceutical Industries Miscellaneous Antimalarials Revenue in Global Market (2017-2022)
        7.2.5 Teva Pharmaceutical Industries Key News
    7.3 Bayer AG.
        7.3.1 Bayer AG. Corporate Summary
        7.3.2 Bayer AG. Business Overview
        7.3.3 Bayer AG. Miscellaneous Antimalarials Major Product Offerings
        7.3.4 Bayer AG. Miscellaneous Antimalarials Revenue in Global Market (2017-2022)
        7.3.5 Bayer AG. Key News
    7.4 GlaxoSmithKline Plc.
        7.4.1 GlaxoSmithKline Plc. Corporate Summary
        7.4.2 GlaxoSmithKline Plc. Business Overview
        7.4.3 GlaxoSmithKline Plc. Miscellaneous Antimalarials Major Product Offerings
        7.4.4 GlaxoSmithKline Plc. Miscellaneous Antimalarials Revenue in Global Market (2017-2022)
        7.4.5 GlaxoSmithKline Plc. Key News
    7.5 Ipca Laboratories Ltd.
        7.5.1 Ipca Laboratories Ltd. Corporate Summary
        7.5.2 Ipca Laboratories Ltd. Business Overview
        7.5.3 Ipca Laboratories Ltd. Miscellaneous Antimalarials Major Product Offerings
        7.5.4 Ipca Laboratories Ltd. Miscellaneous Antimalarials Revenue in Global Market (2017-2022)
        7.5.5 Ipca Laboratories Ltd. Key News
    7.6 Milan Pharmaceuticals
        7.6.1 Milan Pharmaceuticals Corporate Summary
        7.6.2 Milan Pharmaceuticals Business Overview
        7.6.3 Milan Pharmaceuticals Miscellaneous Antimalarials Major Product Offerings
        7.6.4 Milan Pharmaceuticals Miscellaneous Antimalarials Revenue in Global Market (2017-2022)
        7.6.5 Milan Pharmaceuticals Key News
    7.7 Paso Laboratories
        7.7.1 Paso Laboratories Corporate Summary
        7.7.2 Paso Laboratories Business Overview
        7.7.3 Paso Laboratories Miscellaneous Antimalarials Major Product Offerings
        7.7.4 Paso Laboratories Miscellaneous Antimalarials Revenue in Global Market (2017-2022)
        7.7.5 Paso Laboratories Key News
    7.8 Glenmark Pharmaceutical Inc.
        7.8.1 Glenmark Pharmaceutical Inc. Corporate Summary
        7.8.2 Glenmark Pharmaceutical Inc. Business Overview
        7.8.3 Glenmark Pharmaceutical Inc. Miscellaneous Antimalarials Major Product Offerings
        7.8.4 Glenmark Pharmaceutical Inc. Miscellaneous Antimalarials Revenue in Global Market (2017-2022)
        7.8.5 Glenmark Pharmaceutical Inc. Key News
    7.9 Zydus Cadila
        7.9.1 Zydus Cadila Corporate Summary
        7.9.2 Zydus Cadila Business Overview
        7.9.3 Zydus Cadila Miscellaneous Antimalarials Major Product Offerings
        7.9.4 Zydus Cadila Miscellaneous Antimalarials Revenue in Global Market (2017-2022)
        7.9.5 Zydus Cadila Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Miscellaneous Antimalarials Market Opportunities & Trends in Global Market
    Table 2. Miscellaneous Antimalarials Market Drivers in Global Market
    Table 3. Miscellaneous Antimalarials Market Restraints in Global Market
    Table 4. Key Players of Miscellaneous Antimalarials in Global Market
    Table 5. Top Miscellaneous Antimalarials Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Miscellaneous Antimalarials Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Miscellaneous Antimalarials Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Miscellaneous Antimalarials Product Type
    Table 9. List of Global Tier 1 Miscellaneous Antimalarials Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Miscellaneous Antimalarials Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Miscellaneous Antimalarials Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Miscellaneous Antimalarials Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Miscellaneous Antimalarials Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Miscellaneous Antimalarials Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Miscellaneous Antimalarials Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Miscellaneous Antimalarials Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Miscellaneous Antimalarials Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Miscellaneous Antimalarials Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Miscellaneous Antimalarials Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Miscellaneous Antimalarials Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Miscellaneous Antimalarials Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Miscellaneous Antimalarials Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Miscellaneous Antimalarials Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Miscellaneous Antimalarials Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Miscellaneous Antimalarials Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Miscellaneous Antimalarials Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Miscellaneous Antimalarials Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Miscellaneous Antimalarials Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Miscellaneous Antimalarials Revenue, (US$, Mn), 2023-2028
    Table 30. Norvatis Corporate Summary
    Table 31. Norvatis Miscellaneous Antimalarials Product Offerings
    Table 32. Norvatis Miscellaneous Antimalarials Revenue (US$, Mn), (2017-2022)
    Table 33. Teva Pharmaceutical Industries Corporate Summary
    Table 34. Teva Pharmaceutical Industries Miscellaneous Antimalarials Product Offerings
    Table 35. Teva Pharmaceutical Industries Miscellaneous Antimalarials Revenue (US$, Mn), (2017-2022)
    Table 36. Bayer AG. Corporate Summary
    Table 37. Bayer AG. Miscellaneous Antimalarials Product Offerings
    Table 38. Bayer AG. Miscellaneous Antimalarials Revenue (US$, Mn), (2017-2022)
    Table 39. GlaxoSmithKline Plc. Corporate Summary
    Table 40. GlaxoSmithKline Plc. Miscellaneous Antimalarials Product Offerings
    Table 41. GlaxoSmithKline Plc. Miscellaneous Antimalarials Revenue (US$, Mn), (2017-2022)
    Table 42. Ipca Laboratories Ltd. Corporate Summary
    Table 43. Ipca Laboratories Ltd. Miscellaneous Antimalarials Product Offerings
    Table 44. Ipca Laboratories Ltd. Miscellaneous Antimalarials Revenue (US$, Mn), (2017-2022)
    Table 45. Milan Pharmaceuticals Corporate Summary
    Table 46. Milan Pharmaceuticals Miscellaneous Antimalarials Product Offerings
    Table 47. Milan Pharmaceuticals Miscellaneous Antimalarials Revenue (US$, Mn), (2017-2022)
    Table 48. Paso Laboratories Corporate Summary
    Table 49. Paso Laboratories Miscellaneous Antimalarials Product Offerings
    Table 50. Paso Laboratories Miscellaneous Antimalarials Revenue (US$, Mn), (2017-2022)
    Table 51. Glenmark Pharmaceutical Inc. Corporate Summary
    Table 52. Glenmark Pharmaceutical Inc. Miscellaneous Antimalarials Product Offerings
    Table 53. Glenmark Pharmaceutical Inc. Miscellaneous Antimalarials Revenue (US$, Mn), (2017-2022)
    Table 54. Zydus Cadila Corporate Summary
    Table 55. Zydus Cadila Miscellaneous Antimalarials Product Offerings
    Table 56. Zydus Cadila Miscellaneous Antimalarials Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Miscellaneous Antimalarials Segment by Type in 2021
    Figure 2. Miscellaneous Antimalarials Segment by Application in 2021
    Figure 3. Global Miscellaneous Antimalarials Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Miscellaneous Antimalarials Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Miscellaneous Antimalarials Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Miscellaneous Antimalarials Revenue in 2021
    Figure 8. By Type - Global Miscellaneous Antimalarials Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Miscellaneous Antimalarials Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Miscellaneous Antimalarials Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Miscellaneous Antimalarials Revenue Market Share, 2017-2028
    Figure 12. US Miscellaneous Antimalarials Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Miscellaneous Antimalarials Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Miscellaneous Antimalarials Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Miscellaneous Antimalarials Revenue Market Share, 2017-2028
    Figure 16. Germany Miscellaneous Antimalarials Revenue, (US$, Mn), 2017-2028
    Figure 17. France Miscellaneous Antimalarials Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Miscellaneous Antimalarials Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Miscellaneous Antimalarials Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Miscellaneous Antimalarials Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Miscellaneous Antimalarials Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Miscellaneous Antimalarials Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Miscellaneous Antimalarials Revenue Market Share, 2017-2028
    Figure 24. China Miscellaneous Antimalarials Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Miscellaneous Antimalarials Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Miscellaneous Antimalarials Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Miscellaneous Antimalarials Revenue, (US$, Mn), 2017-2028
    Figure 28. India Miscellaneous Antimalarials Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Miscellaneous Antimalarials Revenue Market Share, 2017-2028
    Figure 30. Brazil Miscellaneous Antimalarials Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Miscellaneous Antimalarials Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Miscellaneous Antimalarials Revenue Market Share, 2017-2028
    Figure 33. Turkey Miscellaneous Antimalarials Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Miscellaneous Antimalarials Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Miscellaneous Antimalarials Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Miscellaneous Antimalarials Revenue, (US$, Mn), 2017-2028
    Figure 37. Norvatis Miscellaneous Antimalarials Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Teva Pharmaceutical Industries Miscellaneous Antimalarials Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Bayer AG. Miscellaneous Antimalarials Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. GlaxoSmithKline Plc. Miscellaneous Antimalarials Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Ipca Laboratories Ltd. Miscellaneous Antimalarials Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Milan Pharmaceuticals Miscellaneous Antimalarials Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Paso Laboratories Miscellaneous Antimalarials Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Glenmark Pharmaceutical Inc. Miscellaneous Antimalarials Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Zydus Cadila Miscellaneous Antimalarials Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
64
Frequently Asked Questions
Miscellaneous Antimalarials Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Miscellaneous Antimalarials Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Miscellaneous Antimalarials Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports